%0 Journal Article
%T Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India
%A Anusha Thota
%A Bikash Medhi
%A Gyanendra Nath Singh
%A Pramod Kumar
%A Prasad Thota
%A Shabir Sidhu
%A V. Kalai Selvan
%J Archive of "Perspectives in Clinical Research".
%D 2018
%R 10.4103/picr.PICR_29_17
%X The National Coordination Centre-Pharmacovigilance Programme of India (NCC-PvPI), Indian Pharmacopoeia Commission works under the aegis of Ministry of Health and Family Welfare, Government of India. It promotes patient safety in India and also supports postmarketing surveillance programs. Currently, almost hundred thousand case reports are submitted to NCC-PvPI each year through its 250 ADR Monitoring Centers (AMCs) located across India, and India is the one of the top ten contributor countries under WHO-Uppsala Monitoring Centre since 2012 and start issuing drug safety alerts from March 2016
%K Drug safety alerts
%K pharmacovigilance
%K Pharmacovigilance Programme of India
%K spontaneous reporting
%K targeted reporting
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799955/